[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

PT Kimia Farma Tbk (KAEF) - Financial and Strategic SWOT Analysis Review

September 2021 | 39 pages | ID: P236A7E92E9EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
PT Kimia Farma Tbk (KAEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

PT Kimia Farma Tbk (Kimia Farma), formerly PT Kimia Farma (Persero) Tbk, manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system anaesthetic, local and general antibiotic, antidotes and detoxifying, cardiovascular and hematopoietic, dermatological, eye and ear, genito - urinary system, hormones, intravenous and other sterile, metabolism, neuromuscular, other chemoterapetics, respiratory, vitamin and minerals and others. Kimia Farma distributes its products in various countries across the world including Asia, Europe and Africa. The company operates manufacturing plants in Jakarta, Bandung, Semarang, Watudakon, Medan and West Java among others. Kimia Farma is headquartered in Jakarta, Indonesia.

PT Kimia Farma Tbk Key Recent Developments

Apr 11,2020: ANTAM and The West Kalimantan SOEs Covid-19 handling group distributes medical equipment

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

PT Kimia Farma Tbk - Key Facts
PT Kimia Farma Tbk - Key Employees
PT Kimia Farma Tbk - Major Products and Services
PT Kimia Farma Tbk - History
PT Kimia Farma Tbk - Company Statement
PT Kimia Farma Tbk - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
PT Kimia Farma Tbk - Business Description
Business Segment: Distribution
Overview
Performance
Business Segment: Manufacture
Overview
Performance
Business Segment: Others
Performance
Business Segment: Retail
Overview
Performance
R&D Overview
PT Kimia Farma Tbk - Corporate Strategy
PT Kimia Farma Tbk - SWOT Analysis
SWOT Analysis - Overview
PT Kimia Farma Tbk - Strengths
PT Kimia Farma Tbk - Weaknesses
PT Kimia Farma Tbk - Opportunities
PT Kimia Farma Tbk - Threats
PT Kimia Farma Tbk - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

PT Kimia Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
PT Kimia Farma Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
PT Kimia Farma Tbk, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 11, 2020: ANTAM and The West Kalimantan SOEs Covid-19 handling group distributes medical equipment

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

PT Kimia Farma Tbk, Key Facts
PT Kimia Farma Tbk, Key Employees
PT Kimia Farma Tbk, Major Products and Services
PT Kimia Farma Tbk, History
PT Kimia Farma Tbk, Other Locations
PT Kimia Farma Tbk, Subsidiaries
PT Kimia Farma Tbk, Joint Venture
PT Kimia Farma Tbk, Key Competitors
PT Kimia Farma Tbk, Ratios based on current share price
PT Kimia Farma Tbk, Annual Ratios
PT Kimia Farma Tbk, Annual Ratios (Cont...1)
PT Kimia Farma Tbk, Annual Ratios (Cont...2)
PT Kimia Farma Tbk, Interim Ratios
PT Kimia Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
PT Kimia Farma Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
PT Kimia Farma Tbk, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

PT Kimia Farma Tbk, Performance Chart (2016 - 2020)
PT Kimia Farma Tbk, Ratio Charts
PT Kimia Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
PT Kimia Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications